Company code: 305287308
Contact the company (B2B)
Biotech, biochemical, and pharmaceutical industry
  • Biotechnology

EmPlastrum was founded in 2019 by a group of engineers and dermatologists who wanted to create a better way for psoriasis treatment. More than 125 million people worldwide suffer from this disease. Due to the fact, that it is an autoimmune skin disease - it never goes away.

Current export markets:
Export turnover: 0%
  • Germany
  • 1-9 Employees
  • 2019Year of establishment
Emplastrum shifts psoriasis treatment from hospitals to homes

Devices for psoriasis treatment